Rutgers University-New Brunswick

Rutgers Is Study Site for Monitoring and Predicting Kidney Risk in COVID-19 Patients

Researchers anticipate a surge in chronic kidney disease and kidney failure post-COVID-19

Newswise — Rutgers New Jersey Medical School will be a clinical test site for a study assessing the long term risk of chronic kidney disease in patients who recover from COVID-19.

The “Multi-Center Assessment of Survivors for Kidney Disease after COVID-19 (MASKeD-COVID) study – conducted by the Division of Nephrology at Mount Sinai – will assess risk in up to 4,000 patients who have recovered from COVID-19 using the artificial-intelligence diagnostic system KidneyIntelX that can incorporate novel protein biomarkers and provide insight into the disease.

Researchers will also study patients’ COVID-19 antibody levels over time, which will provide insights into the interaction between immune response and kidney-related complications. Initial research findings are expected to be reported in early 2021.

SARS-CoV-2, the virus that causes COVID-19, is believed to result in acute kidney injury in many ways, including severe inflammation, damage to the thin layer of cells that line blood vessels, clots in small blood vessels and possibly direct invasion of the virus into kidney cells that are responsible for filtration of the blood.

As of the second week of September 2020, more than 389,000 Americans have been hospitalized for COVID-19. Approximately 20 percent to 45 percent of those patients — and more than 60 percent of those admitted to the ICU for COVID-19 — have acute kidney injury. Of these, about 25 percent to 45 percent require acute dialysis.

“Emerging evidence suggests that patients who survive COVID-19 will experience a significant increased risk of kidney disease. There are many questions that still need to be answered regarding COVID-19 and kidney disease, such as whether there are any protein biomarkers that could predict if recovered patients will develop chronic kidney disease as a long-term outcome of COVID-19,” said Hong Li, the study’s principal investigator at Rutgers New Jersey Medical School. “Our team at the Rutgers Center for Advanced Proteomics Research will use state-of-the-art proteomics technologies to identify and validate potential novel protein biomarkers in patient urine samples. By integrating these protein data with other data from partner institutions, scientists at Mount Sinai Division of Nephrology will use artificial intelligence to assess the longitudinal progression and treatments of kidney disease in COVID-19 patients.”

Filters close

Showing results

110 of 3380
access_time Embargo lifts in 2 days
Embargo will expire: 24-Sep-2020 2:00 PM EDT Released to reporters: 24-Sep-2020 9:25 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Sep-2020 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 24-Sep-2020 5:05 AM EDT
Many Americans continue to maintain unhealthy lifestyle habits during COVID-19; overeating, alcohol drinking and marijuana use increase while exercise declines, reports USC Center for the Digital Future
USC Annenberg School for Communication and Journalism

After more than six months of living in a pandemic, large percentages of Americans continue to indulge in unhealthy lifestyle habits, including overeating and increased use of alcohol and marijuana — all while many are exercising less, according to a study of the cultural impact of COVID-19 conducted by the USC Center for the Digital Future (CDF).

Newswise: Houston Methodist COVID-19 study shows rapid spread and potential for mutant viruses
Released: 23-Sep-2020 4:55 PM EDT
Houston Methodist COVID-19 study shows rapid spread and potential for mutant viruses
Houston Methodist

Molecular analysis of COVID-19’s powerful second wave in Houston shows a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston’s first wave. Gene sequencing results from 5,085 COVID-positive patients tested at Houston Methodist since early March show a virus capable of adapting, surviving and thriving – making it more important than ever for physician scientists to understand its evolution as they work to discover effective vaccines and therapies.

Newswise: Likely molecular mechanisms of SARS-CoV-2 pathogenesis are revealed by network biology
Released: 23-Sep-2020 4:00 PM EDT
Likely molecular mechanisms of SARS-CoV-2 pathogenesis are revealed by network biology
University of Alabama at Birmingham

Researchers combined a lung-epithelial cell host interactome with a SARS-CoV-2 interactome. Network biology analysis of this human/SARS-CoV-2 interactome revealed potential molecular mechanisms of pathogenesis for SARS-CoV-2, the virus responsible for the COVID-19 pandemic.

Newswise: Statins Reduce COVID-19 Severity, Likely by Removing Cholesterol That Virus Uses to Infect
Released: 23-Sep-2020 3:45 PM EDT
Statins Reduce COVID-19 Severity, Likely by Removing Cholesterol That Virus Uses to Infect
University of California San Diego Health

Analyzing anonymized patient medical records, UC San Diego researchers discovered that cholesterol-lowering statins reduced risk of severe COVID-19 infection, while lab experiments uncovered a cellular mechanism that helps explain why.

Newswise: Flu Season Returns As The COVID-19 Pandemic Continues
Released: 23-Sep-2020 2:00 PM EDT
Flu Season Returns As The COVID-19 Pandemic Continues
Johns Hopkins Medicine

As the COVID-19 pandemic continues with no end in sight, the annual flu season emerges once again. Cases of the flu have already begun to surface around the nation, and there are some reports of co-infection with COVID-19. Johns Hopkins Medicine experts say now is the time to take action to fight against the flu. Doctors recommend that everyone age 6 months and older get the flu vaccine each year to prevent infection from the virus or reduce the severity of the illness.

Released: 23-Sep-2020 1:45 PM EDT
Mathematics: Modelling the timings of a COVID-19 second wave in Europe
Scientific Reports

How a second wave of COVID-19 infections may evolve across Europe over the next few months, using data on infection rates and travel within and between European countries, is modelled in a Scientific Reports paper.

Released: 23-Sep-2020 1:20 PM EDT
Study: Death counts fail to capture full mortality effects of COVID-19
University of South Florida

More than 200,000 people in the U.S. have died from COVID-19.

Released: 23-Sep-2020 1:10 PM EDT
Q&A: What’s in store for retailers during a pandemic holiday season?
Michigan State University

The 2020 holiday season, much like the majority of the year, will be like none other before. But what does this mean for retailers? Simone Peinkofer, assistant professor of supply chain management at Michigan State University’s Eli Broad College of Business, discusses what holiday consumerism may look like for consumers and retailers alike.

Released: 23-Sep-2020 1:05 PM EDT
UK lockdown and air pollution: Nitrogen dioxide halved but sulphur dioxide doubled
University of Liverpool

A University of Liverpool study of air pollution in the UK during the first 100 days of lockdown has revealed that whilst nitrogen oxide levels were cut by half, levels of sulphur dioxide increased by over 100%.

Showing results

110 of 3380